GENETIC-POLYMORPHISM OF CYP2C9 AND ITS EFFECT ON WARFARIN MAINTENANCEDOSE REQUIREMENT IN PATIENTS UNDERGOING ANTICOAGULATION THERAPY

Authors
FURUYA H FERNANDEZSALGUERO P GREGORY W TABER H STEWARD A GONZALEZ FJ IDLE JR
Citation
H. Furuya et al., GENETIC-POLYMORPHISM OF CYP2C9 AND ITS EFFECT ON WARFARIN MAINTENANCEDOSE REQUIREMENT IN PATIENTS UNDERGOING ANTICOAGULATION THERAPY, Pharmacogenetics, 5(6), 1995, pp. 389-392
Citations number
11
Categorie Soggetti
Pharmacology & Pharmacy","Genetics & Heredity
Journal title
Pharmacogenetics → ACNP
ISSN journal
0960314X
Volume
5
Issue
6
Year of publication
1995
Pages
389 - 392
Database
ISI
SICI code
0960-314X(1995)5:6<389:GOCAIE>2.0.ZU;2-K